KR20180110237A - 아실 설폰아미드의 다형체 - Google Patents

아실 설폰아미드의 다형체 Download PDF

Info

Publication number
KR20180110237A
KR20180110237A KR1020187028288A KR20187028288A KR20180110237A KR 20180110237 A KR20180110237 A KR 20180110237A KR 1020187028288 A KR1020187028288 A KR 1020187028288A KR 20187028288 A KR20187028288 A KR 20187028288A KR 20180110237 A KR20180110237 A KR 20180110237A
Authority
KR
South Korea
Prior art keywords
compound
formula
crystalline form
ray powder
powder diffraction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1020187028288A
Other languages
English (en)
Korean (ko)
Inventor
제임스 프렌티스 데비드슨
마이클 마틴
페이 팡
마가렛 웡
Original Assignee
에프. 호프만-라 로슈 아게
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 에프. 호프만-라 로슈 아게 filed Critical 에프. 호프만-라 로슈 아게
Priority to KR1020217027200A priority Critical patent/KR102437499B1/ko
Publication of KR20180110237A publication Critical patent/KR20180110237A/ko
Ceased legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/50—Compounds containing any of the groups, X being a hetero atom, Y being any atom
    • C07C311/51—Y being a hydrogen or a carbon atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/36—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/42—Separation; Purification; Stabilisation; Use of additives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • AIDS & HIV (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
KR1020187028288A 2008-09-09 2009-08-31 아실 설폰아미드의 다형체 Ceased KR20180110237A (ko)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020217027200A KR102437499B1 (ko) 2008-09-09 2009-08-31 아실 설폰아미드의 다형체

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US9536408P 2008-09-09 2008-09-09
US61/095,364 2008-09-09
PCT/EP2009/061185 WO2010028968A2 (en) 2008-09-09 2009-08-31 Polymorphs of acyl sulfonamides

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
KR1020177036902A Division KR20180001582A (ko) 2008-09-09 2009-08-31 아실 설폰아미드의 다형체

Related Child Applications (1)

Application Number Title Priority Date Filing Date
KR1020217027200A Division KR102437499B1 (ko) 2008-09-09 2009-08-31 아실 설폰아미드의 다형체

Publications (1)

Publication Number Publication Date
KR20180110237A true KR20180110237A (ko) 2018-10-08

Family

ID=41664548

Family Applications (7)

Application Number Title Priority Date Filing Date
KR1020187028288A Ceased KR20180110237A (ko) 2008-09-09 2009-08-31 아실 설폰아미드의 다형체
KR1020237025164A Ceased KR20230113420A (ko) 2008-09-09 2009-08-31 아실 설폰아미드의 다형체
KR1020177036902A Ceased KR20180001582A (ko) 2008-09-09 2009-08-31 아실 설폰아미드의 다형체
KR1020227029185A Active KR102560207B1 (ko) 2008-09-09 2009-08-31 아실 설폰아미드의 다형체
KR1020167020205A Active KR101822319B1 (ko) 2008-09-09 2009-08-31 아실 설폰아미드의 다형체
KR1020117005435A Active KR101678700B1 (ko) 2008-09-09 2009-08-31 아실 설폰아미드의 다형체
KR1020217027200A Active KR102437499B1 (ko) 2008-09-09 2009-08-31 아실 설폰아미드의 다형체

Family Applications After (6)

Application Number Title Priority Date Filing Date
KR1020237025164A Ceased KR20230113420A (ko) 2008-09-09 2009-08-31 아실 설폰아미드의 다형체
KR1020177036902A Ceased KR20180001582A (ko) 2008-09-09 2009-08-31 아실 설폰아미드의 다형체
KR1020227029185A Active KR102560207B1 (ko) 2008-09-09 2009-08-31 아실 설폰아미드의 다형체
KR1020167020205A Active KR101822319B1 (ko) 2008-09-09 2009-08-31 아실 설폰아미드의 다형체
KR1020117005435A Active KR101678700B1 (ko) 2008-09-09 2009-08-31 아실 설폰아미드의 다형체
KR1020217027200A Active KR102437499B1 (ko) 2008-09-09 2009-08-31 아실 설폰아미드의 다형체

Country Status (16)

Country Link
US (1) US8063103B2 (https=)
EP (1) EP2334638B1 (https=)
JP (6) JP5989339B2 (https=)
KR (7) KR20180110237A (https=)
CN (1) CN102143943B (https=)
AU (1) AU2009290988B2 (https=)
BR (3) BR122021020474B1 (https=)
CA (5) CA3003213C (https=)
EA (1) EA019340B1 (https=)
ES (1) ES2706875T3 (https=)
IL (4) IL299322B2 (https=)
MX (1) MX2011002319A (https=)
PL (1) PL2334638T3 (https=)
TR (1) TR201818979T4 (https=)
UA (1) UA107561C2 (https=)
WO (1) WO2010028968A2 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2644156C1 (ru) 2017-02-28 2018-02-08 Александр Васильевич Иващенко Пролекарство ингибитора NS5B HCV полимеразы, способ его получения и применения
RU2665383C9 (ru) * 2017-06-22 2019-07-23 Общество с ограниченной ответственностью "Вириом" Фармацевтическая наносуспензия для терапии ВИЧ-инфекции
RU2662160C9 (ru) * 2017-07-03 2018-10-22 Александрович Иващенко Андрей Комбинированный лекарственный препарат для терапии вирусных инфекций
RU2716257C1 (ru) * 2019-04-30 2020-03-11 Андрей Александрович Иващенко Активный компонент, фармацевтическая композиция и лекарственный препарат для терапии ВИЧ и СПИДа
RU2717101C1 (ru) 2019-06-03 2020-03-18 Андрей Александрович Иващенко Анелированные 9-гидрокси-1,8-диоксо-1,3,4,8-тетрагидро-2Н-пиридо[1,2-a]пиразин-7-карбоксамиды - ингибиторы интегразы ВИЧ, способы их получения и применения

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ID21546A (id) * 1997-01-23 1999-06-24 Yamanouchi Pharmaceuticl Co Lt Turunan-turunan amida baru dan komposisi-komposisi obat darinya
US7166738B2 (en) * 2004-04-23 2007-01-23 Roche Palo Alto Llc Non-nucleoside reverse transcriptase inhibitors
DE602005017604D1 (de) * 2004-04-23 2009-12-24 Hoffmann La Roche Inhibitoren der nicht-nukleosid-inhibitoren der reversen transkriptase
US7625949B2 (en) 2004-04-23 2009-12-01 Roche Palo Alto Llc Methods for treating retroviral infections
US7618981B2 (en) * 2004-05-06 2009-11-17 Cytokinetics, Inc. Imidazopyridinyl-benzamide anti-cancer agents
JP4173909B1 (ja) * 2005-04-28 2008-10-29 ファイザー・リミテッド アミノ酸誘導体
WO2009018233A1 (en) * 2007-07-30 2009-02-05 Ardea Biosciences, Inc. Derivatives of n-(arylamino) sulfonamides including polymorphs as inhibitors of mek as well as compositions, methods of use and methods for preparing the same
WO2007045573A1 (en) * 2005-10-19 2007-04-26 F. Hoffmann-La Roche Ag Phenyl-acetamide nnrt inhibitors
CA2716082A1 (en) * 2008-03-04 2009-02-23 F. Hoffmann-La Roche Ag Process for preparing concentrated aqueous micellar solutions

Also Published As

Publication number Publication date
IL299322B2 (en) 2024-10-01
JP2021176894A (ja) 2021-11-11
IL299322B1 (en) 2024-06-01
JP2018058862A (ja) 2018-04-12
CN102143943A (zh) 2011-08-03
CA2735192C (en) 2017-02-28
CN102143943B (zh) 2014-03-12
KR101678700B1 (ko) 2016-11-22
EA201100451A1 (ru) 2011-10-31
JP6450340B2 (ja) 2019-01-09
KR20110053234A (ko) 2011-05-19
CA2735192A1 (en) 2010-03-18
IL299322A (en) 2023-02-01
IL211353A0 (en) 2011-05-31
JP2012502075A (ja) 2012-01-26
AU2009290988B2 (en) 2016-01-28
AU2009290988A1 (en) 2010-03-18
JP2023082131A (ja) 2023-06-13
CA3003213C (en) 2021-07-20
EP2334638B1 (en) 2018-11-21
JP2019194229A (ja) 2019-11-07
CA3059552A1 (en) 2010-03-18
MX2011002319A (es) 2011-04-05
KR20210108499A (ko) 2021-09-02
KR20160092049A (ko) 2016-08-03
ES2706875T3 (es) 2019-04-01
CA3003213A1 (en) 2010-03-18
BR122021020474B1 (pt) 2022-06-07
KR101822319B1 (ko) 2018-01-25
BR122021020475B1 (pt) 2022-06-07
JP5989339B2 (ja) 2016-09-07
KR20230113420A (ko) 2023-07-28
TR201818979T4 (tr) 2019-01-21
CA3086566A1 (en) 2010-03-18
KR102437499B1 (ko) 2022-08-29
IL264118A (en) 2019-02-28
CA3086566C (en) 2025-09-02
IL244350A0 (en) 2016-05-01
US20100063154A1 (en) 2010-03-11
CA2949912C (en) 2019-12-03
BRPI0918526A2 (pt) 2015-12-01
WO2010028968A2 (en) 2010-03-18
EP2334638A2 (en) 2011-06-22
KR102560207B1 (ko) 2023-07-27
PL2334638T3 (pl) 2019-04-30
EA019340B1 (ru) 2014-02-28
WO2010028968A3 (en) 2010-06-10
IL211353A (en) 2016-04-21
KR20220120723A (ko) 2022-08-30
BRPI0918526B1 (pt) 2022-02-15
CA2949912A1 (en) 2010-03-18
KR20180001582A (ko) 2018-01-04
UA107561C2 (xx) 2015-01-26
CA3059552C (en) 2021-03-16
US8063103B2 (en) 2011-11-22
JP2016172741A (ja) 2016-09-29

Similar Documents

Publication Publication Date Title
JP4627315B2 (ja) 非ヌクレオシド逆転写酵素阻害剤としてのベンジルピリダジノン誘導体
JP2023082131A (ja) アシルスルホンアミドの多形体

Legal Events

Date Code Title Description
A107 Divisional application of patent
A201 Request for examination
AMND Amendment
PA0104 Divisional application for international application

Comment text: Divisional Application for International Patent

Patent event code: PA01041R01D

Patent event date: 20181001

Application number text: 1020177036902

Filing date: 20171221

PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20181001

Comment text: Request for Examination of Application

PG1501 Laying open of application
E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20181016

Patent event code: PE09021S01D

AMND Amendment
E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20210128

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20181016

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I

X091 Application refused [patent]
AMND Amendment
PX0901 Re-examination

Patent event code: PX09011S01I

Patent event date: 20210128

Comment text: Decision to Refuse Application

Patent event code: PX09012R01I

Patent event date: 20200831

Comment text: Amendment to Specification, etc.

Patent event code: PX09012R01I

Patent event date: 20181001

Comment text: Amendment to Specification, etc.

PX0601 Decision of rejection after re-examination

Comment text: Decision to Refuse Application

Patent event code: PX06014S01D

Patent event date: 20210526

Comment text: Amendment to Specification, etc.

Patent event code: PX06012R01I

Patent event date: 20210429

Comment text: Decision to Refuse Application

Patent event code: PX06011S01I

Patent event date: 20210128

Comment text: Amendment to Specification, etc.

Patent event code: PX06012R01I

Patent event date: 20200831

Comment text: Notification of reason for refusal

Patent event code: PX06013S01I

Patent event date: 20181016

Comment text: Amendment to Specification, etc.

Patent event code: PX06012R01I

Patent event date: 20181001

X601 Decision of rejection after re-examination
A107 Divisional application of patent
J201 Request for trial against refusal decision
PA0104 Divisional application for international application

Comment text: Divisional Application for International Patent

Patent event code: PA01041R01D

Patent event date: 20210825

Application number text: 1020177036902

Filing date: 20171221

PJ0201 Trial against decision of rejection

Patent event date: 20210825

Comment text: Request for Trial against Decision on Refusal

Patent event code: PJ02012R01D

Patent event date: 20210526

Comment text: Decision to Refuse Application

Patent event code: PJ02011S01I

Patent event date: 20210128

Comment text: Decision to Refuse Application

Patent event code: PJ02011S01I

Appeal kind category: Appeal against decision to decline refusal

Decision date: 20211210

Appeal identifier: 2021101002204

Request date: 20210825

PJ0801 Rejection of trial

Decision date: 20211210

Appeal kind category: Appeal against decision to decline refusal

Appeal identifier: 2021101002204

Request date: 20210825